Virtual healthcare services, or telehealth, are rapidly becoming a standard of care in the expanding digital healthcare space ...

HIMS and LFMD are surging in the telehealth race, but which one has stronger earnings growth and expansion momentum? Let's see.

Hims & Hers is a consumer-first platform transforming the way customers fulfill their health and wellness needs, while LifeMD is a direct-to-patient telehealth company that provides a cost-effective ...

Novo Nordisk said on Thursday it will collaborate with WeightWatchers to sell its blockbuster weight-loss drug Wegovy, starting July 1. Under the deal, cash-paying patients can access a month's supply ...

Novo Nordisk confirmed that its partnerships with LifeMD and Ro will continue as the pharmaceutical giant expands patient access to its weight-loss drug Wegovy. The company also announced a new ...

Novo Nordisk announces collaboration with WeightWatchers to offer patients living with obesity access to FDA-approved Wegovy® through NovoCare® PharmacyRo and LifeMD collaborations continue ...

Novo Nordisk confirmed that its partnerships with LifeMD and Ro will continue as the pharmaceutical giant expands patient access to its weight-loss drug Wegovy.

LifeMD Inc. Annual cash flow by MarketWatch. View LFMD net cash flow, operating cash flow, operating expenses and cash dividends.

A unique business structure gives LifeMD access to the growing GLP-1 marketplace that can help boost the heavily shorted stock price. Read an analysis of LFMD here.

LifeMD is bordering on breakeven, according to the 7 American Healthcare Services analysts. They anticipate the company to incur a final loss in 2024, before generating positive profits of US$2.3m ...